EichorEICHOR
Condition: Limited Stage Small Cell Lung Cancer Ls Sclc Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Limited Stage Small Cell Lung Cancer Ls Sclc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in th
Phase 2 · 1 location(s) · Fudan University · NCT06943235Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
Phase 2/Phase 3 · 1 location(s) · Sun Yat-sen University · NCT05623267Durvalumab as Consolidation for Patients LS-SCLC
Phase 2 · 2 location(s) · Qian Chu · NCT07055581A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage
Phase 2 · 2 location(s) · Henan Cancer Hospital · NCT07559786Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-om
Phase N/A · 1 location(s) · Peking University Cancer Hospital & Institute · NCT06869239Omitting CTV for Primary Tumor in LS-SCLC
Phase 3 · 2 location(s) · Sun Yat-sen University · NCT07008716A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limite
Phase 2 · 1 location(s) · Shanghai Chest Hospital · NCT07091305Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited
Phase 3 · 76 location(s) · Shanghai Junshi Bioscience Co., Ltd. · NCT06095583Serplulimab Combined With CCRT for LS-SCLC.
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT06295926Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)
Phase 2 · 1 location(s) · Guangdong Provincial People's Hospital · NCT06911606Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT
Phase N/A · 4 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07309211Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06719700BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Phase 2 · 33 location(s) · SCRI Development Innovations, LLC · NCT06773910
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.